Two Sigma Investments, LP Sqz Biotechnologies CO Transaction History

Two Sigma Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.16 - $3.48 $241 - $389	-112 Reduced 0.82%	13,620 $31,000
Q2 2022 Aug 15, 2022	SELL	$2.77 - $5.0 $71,909 - $129,800	-25,960 Reduced 65.4%	13,732 $44,000
Q1 2022 May 16, 2022	SELL	$4.01 - $10.42 $30,030 - $78,035	-7,489 Reduced 15.87%	39,692 $191,000
Q4 2021 Feb 14, 2022	BUY	$8.93 - $14.85 $42,578 - $70,804	4,768 Added 11.24%	47,181 $421,000
Q3 2021 Nov 15, 2021	BUY	$11.46 - $15.77 $116,227 - $159,939	10,142 Added 31.43%	42,413 $612,000
Q2 2021 Aug 16, 2021	SELL	$11.32 - $14.45 $123,637 - $157,822	-10,922 Reduced 25.29%	32,271 $466,000
Q1 2021 May 17, 2021	BUY	$12.07 - $29.9 $521,339 - $1.29 Million	43,193 New	43,193 $591,000

1.47M

Ticker SQZ
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,248,600
Market Cap $1.46M
Description
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination ...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.